Cargando…
Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement
BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESU...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064191/ https://www.ncbi.nlm.nih.gov/pubmed/32155164 http://dx.doi.org/10.1371/journal.pone.0229721 |
_version_ | 1783504832775061504 |
---|---|
author | Miura, Shiro Inoue, Katsumi Kumamaru, Hiraku Yamashita, Takehiro Hanyu, Michiya Shirai, Shinichi Ando, Kenji |
author_facet | Miura, Shiro Inoue, Katsumi Kumamaru, Hiraku Yamashita, Takehiro Hanyu, Michiya Shirai, Shinichi Ando, Kenji |
author_sort | Miura, Shiro |
collection | PubMed |
description | BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESULTS: We retrospectively included 201 patients (mean age, 75 years; 43%, men) who underwent surgical AVR for severe native AS (aortic valve area ≤1.0 cm(2) on preoperative transthoracic echocardiography examination). The following valve etiologies were postoperatively identified on pathological examination: post-inflammatory (n = 28), congenital (n = 35), and calcific/degenerative (n = 138). The median follow-up interval was 4.1 years following surgical AVR. Of the 201 patients, 27% were asymptomatic, 40% had a history of heart failure, and 11% underwent previous heart surgery. The cumulative incidence of cardiac events (all-cause death, aortic valve deterioration requiring repeated AVR, and hospitalization for heart failure) and combined adverse events, which included non-fatal stroke, unplanned coronary revascularization, pacemaker implantation, and gastrointestinal bleeding along with cardiac events, was significantly higher in the calcific/degenerative group (p = 0.02 and p = 0.02, respectively). In multivariate analysis adjusted for age, sex, renal function, heart failure, atrial fibrillation, concomitant surgical procedures, and EuroSCORE II, AS etiology was independently associated with an increased risk of combined adverse events (congenital vs. post-inflammatory: hazard ratio [HR], 4.13; p = 0.02 and calcific/degenerative vs. post-inflammatory: HR, 5.69; p = 0.002). CONCLUSIONS: Pathology-proven AS etiology could aid in predicting the mid-term outcomes after surgical AVR, supporting the importance of accurate identification of severe AS etiology with or without postoperative pathological examination. |
format | Online Article Text |
id | pubmed-7064191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70641912020-03-23 Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement Miura, Shiro Inoue, Katsumi Kumamaru, Hiraku Yamashita, Takehiro Hanyu, Michiya Shirai, Shinichi Ando, Kenji PLoS One Research Article BACKGROUND: The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated. METHODS AND RESULTS: We retrospectively included 201 patients (mean age, 75 years; 43%, men) who underwent surgical AVR for severe native AS (aortic valve area ≤1.0 cm(2) on preoperative transthoracic echocardiography examination). The following valve etiologies were postoperatively identified on pathological examination: post-inflammatory (n = 28), congenital (n = 35), and calcific/degenerative (n = 138). The median follow-up interval was 4.1 years following surgical AVR. Of the 201 patients, 27% were asymptomatic, 40% had a history of heart failure, and 11% underwent previous heart surgery. The cumulative incidence of cardiac events (all-cause death, aortic valve deterioration requiring repeated AVR, and hospitalization for heart failure) and combined adverse events, which included non-fatal stroke, unplanned coronary revascularization, pacemaker implantation, and gastrointestinal bleeding along with cardiac events, was significantly higher in the calcific/degenerative group (p = 0.02 and p = 0.02, respectively). In multivariate analysis adjusted for age, sex, renal function, heart failure, atrial fibrillation, concomitant surgical procedures, and EuroSCORE II, AS etiology was independently associated with an increased risk of combined adverse events (congenital vs. post-inflammatory: hazard ratio [HR], 4.13; p = 0.02 and calcific/degenerative vs. post-inflammatory: HR, 5.69; p = 0.002). CONCLUSIONS: Pathology-proven AS etiology could aid in predicting the mid-term outcomes after surgical AVR, supporting the importance of accurate identification of severe AS etiology with or without postoperative pathological examination. Public Library of Science 2020-03-10 /pmc/articles/PMC7064191/ /pubmed/32155164 http://dx.doi.org/10.1371/journal.pone.0229721 Text en © 2020 Miura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Miura, Shiro Inoue, Katsumi Kumamaru, Hiraku Yamashita, Takehiro Hanyu, Michiya Shirai, Shinichi Ando, Kenji Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title | Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title_full | Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title_fullStr | Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title_full_unstemmed | Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title_short | Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
title_sort | clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064191/ https://www.ncbi.nlm.nih.gov/pubmed/32155164 http://dx.doi.org/10.1371/journal.pone.0229721 |
work_keys_str_mv | AT miurashiro clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT inouekatsumi clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT kumamaruhiraku clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT yamashitatakehiro clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT hanyumichiya clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT shiraishinichi clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement AT andokenji clinicalimpactofpathologyprovenetiologyofseverelystenoticaorticvalvesonmidtermoutcomesinpatientsundergoingsurgicalaorticvalvereplacement |